- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Gail Wilensky Remains "Hopeful" for Bipartisan Legislation on Healthcare Reform
The healthcare legislation from Senators Bill Cassidy (R-Louisiana) and Susan Collins (R-Maine) was probably the best chance at a bipartisan bill, but there are some Democrats who still seem interested in drafting bipartisan legislation, explained Gail Wilensky, PhD, of Project HOPE.
The healthcare legislation from Senators Bill Cassidy (R-Louisiana) and Susan Collins (R-Maine) was probably the best chance at a bipartisan bill, but there are some Democrats who still seem interested in drafting bipartisan legislation, explained Gail Wilensky, PhD, of Project HOPE.
Transcript
There have been rumors that some Republican senators are interested in working with Democrats to craft a healthcare bill. What do you think is the likelihood of a bipartisan bill being created?
Well, I remain ever hopeful. I find the Cassidy-Collins legislation, which is a likely vehicle to at least start discussions of bipartisan support, very promising since one of the options is if you like the Affordable Care Act you can keep the Affordable Care Act in your state with a very small haircut of 5% for the subsidies.
I was very disappointed that the Democratic leadership in the Senate just trashed that idea when it was first raised because I think it genuinely was an attempt to do outreach to Democrats to see whether they couldn’t come to an agreement on a way to allow states that like the Affordable Care Act to keep it and to allow states that wanted to use their money differently to do so within some very confined parameters.
So right now there are only about 3 Senators on the Democratic side that have expressed much interest, but we’ll see what happens in the future.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More
